| n (%) | Median survival (days) | 1 year survival (%) | |
|---|---|---|---|
| All patients | 8,503 (100%) | 278 | 41 |
| Survival was slightly better in females (median 304 days vs 274 days HR 0.91, p= 0.002) | |||
| Subtype | |||
| Unspecified | 3,798 | 276 | 39.5 |
| Epithelioid | 2,300 | 388 | 53.2 |
| Sarcomatoid | 439 | 123 | 16.4 |
| Biphasic | 268 | 274 | 36.0 |